US Patent Issued to Guangzhou Ocusun Ophthalmic Biotechnology on June 17 for "Composition of lanosterol prodrug compound, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,763, issued on June 17, was assigned to Guangzhou Ocusun Ophthalmic Biotechnology Co. Ltd. (Guangzhou, China).

"Composition of lanosterol prodrug compound, preparation method therefor and use thereof" was invented by Yizhi Liu (Guangzhou, China), Yandong Wang (Guangzhou, China), Xiaolin Li (Shanghai), Zhi Luo (Shanghai) and Haiying He (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition includes a compound as shown in formula (I). The compound and composition can be used in the preparation of a drug for treating ophthalmic diseases."

The patent was filed on March 4, 2020, under Application No. 17/435,668.

*For further information...